Clinical Trial Update: Extension Neoadjuvant Taxotere: Study of the Effects of Taxotere in Patients With Breast Cancer [Phase 2]

View source ↗

Summary

This clinical trial update notes the terminated status of an extension phase 2 neoadjuvant study evaluating Taxotere (docetaxel) in patients with breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: Baylor Breast Care Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED